Icos, Glaxo Wellcome deal

Glaxo ended the companies' 1991 collaboration to develop phosphodiesterase (PDE) inhibitors. The

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE